22:00 , May 18, 2018 |  BC Extra  |  Company News

Management tracks: Seattle Genetics, SurModics

Antibody-drug conjugate company Seattle Genetics Inc. (NASDAQ:SGEN) said CMO Jonathan Drachman has stepped down. He is succeeded by Roger Dansey, who was therapeutic area head for late-stage oncology at Merck & Co. Inc. (NYSE:MRK). Medical...
07:00 , Jul 1, 2013 |  BC Week In Review  |  Company News

AmideBio sales and marketing update

AmideBio launched its BioPure Amyloid-beta 1-42 peptide ( beta amyloid 42 ) in laboratory research quantities (50-1,000 µg) for use in Alzheimer's disease (AD) research. The company also markets laboratory research quantities of a number...
08:00 , Feb 8, 2010 |  BC Week In Review  |  Financial News

AmideBio completes venture financing

AmideBio LLC , Aurora, Colo.   Business: Supply/Service   Date completed: 1/26/10   Type: Venture financing   Raised: Undisclosed   Investors: Angel investors  ...